Publication | Closed Access

Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial

HepatologyHepatitis CViral HepatitisAntiviral TherapyHepatitisVirologyChronic Viral InfectionDose-escalation TrialAntiviral DrugMedicineOral Combination TherapyNucleoside Polymerase Inhibitor